• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白细胞介素 6 在类风湿关节炎中的神经内分泌和神经生理学作用。

Neuroendocrine and neurophysiological effects of interleukin 6 in rheumatoid arthritis.

机构信息

Section of Rheumatology, Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, UK.

Rheumatologic and Immunologic Disease, Cleveland Clinic, Cleveland, OH, USA.

出版信息

Rheumatology (Oxford). 2018 Nov 1;57(11):1885-1895. doi: 10.1093/rheumatology/kex391.

DOI:10.1093/rheumatology/kex391
PMID:29186541
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6199533/
Abstract

RA is a chronic, systemic, autoimmune disease characterized by inflammation and degradation of the joints, causing significant negative impact on quality of life. In addition to joint disease, symptoms and co-morbidities associated with RA-namely pain, fatigue and mood disorders-are often as debilitating as the disease itself. The pro-inflammatory cytokine IL-6 plays a critical role in RA-associated pathology. However, a greater understanding of the translational effects of IL-6 outside of the immune system is needed. This review discusses our current understanding of emerging aspects of IL-6 in RA-associated pain, fatigue and mood disorders such as depression and anxiety. This review also describes the clinical effects of IL-6 inhibition on these symptoms and co-morbidities in patients with RA.

摘要

类风湿关节炎是一种慢性、全身性、自身免疫性疾病,其特征为炎症和关节退化,对生活质量造成重大负面影响。除关节疾病外,类风湿关节炎相关的症状和合并症(如疼痛、疲劳和情绪障碍)往往与疾病本身一样具有致残性。促炎细胞因子白细胞介素 6(IL-6)在类风湿关节炎相关病理中起着关键作用。然而,我们需要更深入地了解 IL-6 在免疫系统之外的转化作用。这篇综述讨论了我们目前对 IL-6 在类风湿关节炎相关疼痛、疲劳和情绪障碍(如抑郁和焦虑)中的新兴作用的理解。这篇综述还描述了 IL-6 抑制对类风湿关节炎患者这些症状和合并症的临床效果。

相似文献

1
Neuroendocrine and neurophysiological effects of interleukin 6 in rheumatoid arthritis.白细胞介素 6 在类风湿关节炎中的神经内分泌和神经生理学作用。
Rheumatology (Oxford). 2018 Nov 1;57(11):1885-1895. doi: 10.1093/rheumatology/kex391.
2
Inhibiting interleukin-6 in rheumatoid arthritis.抑制类风湿关节炎中的白细胞介素-6
Curr Rheumatol Rep. 2008 Oct;10(5):413-7. doi: 10.1007/s11926-008-0066-x.
3
Humanized antihuman IL-6 receptor antibody, tocilizumab.人源化抗人白细胞介素-6受体抗体,托珠单抗。
Handb Exp Pharmacol. 2008(181):151-60. doi: 10.1007/978-3-540-73259-4_7.
4
Room for more IL-6 blockade? Sarilumab for the treatment of rheumatoid arthritis.是否有更多的 IL-6 阻断空间? Sarilumab 治疗类风湿关节炎。
Expert Opin Biol Ther. 2016 Oct;16(10):1303-9. doi: 10.1080/14712598.2016.1217988. Epub 2016 Aug 8.
5
Profile of sarilumab and its potential in the treatment of rheumatoid arthritis.托珠单抗简介及其在类风湿关节炎治疗中的潜力。
Drug Des Devel Ther. 2017 May 24;11:1593-1603. doi: 10.2147/DDDT.S100302. eCollection 2017.
6
Tocilizumab in the treatment of rheumatoid arthritis: an evidence-based review and patient selection.托珠单抗治疗类风湿关节炎:基于证据的综述与患者选择
Drug Des Devel Ther. 2018 Dec 19;13:57-70. doi: 10.2147/DDDT.S150580. eCollection 2019.
7
IL-6 inhibitors for treatment of rheumatoid arthritis: past, present, and future.白细胞介素 6 抑制剂治疗类风湿关节炎:过去、现在和未来。
Arch Pharm Res. 2015;38(5):575-84. doi: 10.1007/s12272-015-0569-8. Epub 2015 Feb 4.
8
A Novel Humanized Anti-Interleukin-6 Antibody HZ0408b With Anti-Rheumatoid Arthritis Therapeutic Potential.一种具有抗类风湿性关节炎治疗潜力的新型人源化抗白细胞介素-6抗体HZ0408b。
Front Immunol. 2022 Jan 19;12:816646. doi: 10.3389/fimmu.2021.816646. eCollection 2021.
9
Leucine-rich α2 -glycoprotein as a potential biomarker for joint inflammation during anti-interleukin-6 biologic therapy in rheumatoid arthritis.富含亮氨酸的α2-糖蛋白作为类风湿关节炎抗白细胞介素-6 生物治疗期间关节炎症的潜在生物标志物。
Arthritis Rheumatol. 2015 May;67(8):2056-60. doi: 10.1002/art.39164.
10
Interleukin-6 inhibition and clinical efficacy in rheumatoid arthritis treatment--data from randomized clinical trials.白细胞介素-6抑制与类风湿关节炎治疗的临床疗效——来自随机临床试验的数据
Bull NYU Hosp Jt Dis. 2007;65 Suppl 1:S16-20.

引用本文的文献

1
Association of TNF-α and IL-6 Concentrations with Depression in Patients with Rheumatoid Arthritis.类风湿关节炎患者中肿瘤坏死因子-α和白细胞介素-6浓度与抑郁的关联
Curr Issues Mol Biol. 2025 Jun 5;47(6):419. doi: 10.3390/cimb47060419.
2
Pathogenic Crosstalk Between the Peripheral and Central Nervous System in Rheumatic Diseases: Emerging Evidence and Clinical Implications.风湿性疾病中周围神经系统与中枢神经系统之间的致病性串扰:新证据及临床意义
Int J Mol Sci. 2025 Jun 24;26(13):6036. doi: 10.3390/ijms26136036.
3
Investigating the Mechanism of Action of in the Treatment of Rheumatoid Arthritis Based on Serum Metabolomics and Network Pharmacology.

本文引用的文献

1
Sarilumab improves patient-reported outcomes in rheumatoid arthritis patients with inadequate response/intolerance to tumour necrosis factor inhibitors.对于对肿瘤坏死因子抑制剂反应不足/不耐受的类风湿关节炎患者,托珠单抗可改善患者报告的结局。
RMD Open. 2017 Mar 7;3(1):e000416. doi: 10.1136/rmdopen-2016-000416. eCollection 2017.
2
Efficacy and safety of sirukumab in patients with active rheumatoid arthritis refractory to anti-TNF therapy (SIRROUND-T): a randomised, double-blind, placebo-controlled, parallel-group, multinational, phase 3 study.司库珠单抗治疗抗 TNF 治疗应答不佳的活动性类风湿关节炎患者的疗效和安全性(SIRROUND-T):一项随机、双盲、安慰剂对照、平行分组、多国、3 期研究。
Lancet. 2017 Mar 25;389(10075):1206-1217. doi: 10.1016/S0140-6736(17)30401-4. Epub 2017 Feb 16.
3
基于血清代谢组学和网络药理学探究[药物名称]治疗类风湿关节炎的作用机制
Mar Drugs. 2025 Mar 7;23(3):114. doi: 10.3390/md23030114.
4
Update on tocilizumab in rheumatoid arthritis: a narrative review.托珠单抗治疗类风湿关节炎的最新进展:一篇叙述性综述
Front Immunol. 2025 Feb 24;16:1470488. doi: 10.3389/fimmu.2025.1470488. eCollection 2025.
5
Inflammatory factor Interleukin-6 and its correlation with rheumatoid arthritis: A meta-analysis.炎症因子白细胞介素-6及其与类风湿关节炎的相关性:一项荟萃分析。
Heliyon. 2024 Oct 17;10(23):e39472. doi: 10.1016/j.heliyon.2024.e39472. eCollection 2024 Dec 15.
6
Association of improvement and worsening of depressive symptoms with arthritis.抑郁症状改善和恶化与关节炎的关联。
BMC Geriatr. 2024 Nov 5;24(1):909. doi: 10.1186/s12877-024-05498-w.
7
Tocilizumab Reduces Depression Risk in Rheumatoid Arthritis Patients: A Systematic Review and Meta-Analysis.托珠单抗降低类风湿关节炎患者的抑郁风险:一项系统评价和荟萃分析。
Psychol Res Behav Manag. 2024 Oct 4;17:3419-3441. doi: 10.2147/PRBM.S482409. eCollection 2024.
8
Comprehensive investigation of network pharmacology, computational modeling, and pharmacokinetic assessment to evaluate the efficacy of flavonoids in rheumatoid arthritis.通过网络药理学、计算建模和药代动力学评估对黄酮类化合物在类风湿性关节炎中的疗效进行综合研究。
Mol Divers. 2025 Jun;29(3):2265-2282. doi: 10.1007/s11030-024-10989-4. Epub 2024 Sep 30.
9
Anti-pentraxin 3 antibodies and residual disease activity in rheumatoid arthritis.类风湿关节炎中的抗五聚体蛋白3抗体与残余疾病活动度
Rheumatology (Oxford). 2025 Apr 1;64(4):1672-1678. doi: 10.1093/rheumatology/keae529.
10
How to Distinguish Non-Inflammatory from Inflammatory Pain in RA?如何在 RA 中区分非炎症性疼痛和炎症性疼痛?
Curr Rheumatol Rep. 2024 Dec;26(12):403-413. doi: 10.1007/s11926-024-01159-4. Epub 2024 Aug 9.
Integrating Interleukin-6 into depression diagnosis and treatment.将白细胞介素-6纳入抑郁症的诊断和治疗。
Neurobiol Stress. 2016 Mar 29;4:15-22. doi: 10.1016/j.ynstr.2016.03.003. eCollection 2016 Oct.
4
Efficacy and safety of sarilumab monotherapy versus adalimumab monotherapy for the treatment of patients with active rheumatoid arthritis (MONARCH): a randomised, double-blind, parallel-group phase III trial.托珠单抗单药治疗与阿达木单抗单药治疗对活动性类风湿关节炎患者的疗效和安全性比较(MONARCH):一项随机、双盲、平行组III期试验
Ann Rheum Dis. 2017 May;76(5):840-847. doi: 10.1136/annrheumdis-2016-210310. Epub 2016 Nov 17.
5
The impact of tocilizumab on physical function and quality of life in patients with rheumatoid arthritis: a systematic literature review and interpretation.托珠单抗对类风湿关节炎患者身体功能和生活质量的影响:一项系统的文献综述与解读
Open Access Rheumatol. 2012 Aug 9;4:87-92. doi: 10.2147/OARRR.S14563. eCollection 2012.
6
Spotlight on sirukumab for the treatment of rheumatoid arthritis: the evidence to date.关注用于治疗类风湿关节炎的sirukumab:迄今的证据。
Drug Des Devel Ther. 2016 Sep 26;10:3083-3098. doi: 10.2147/DDDT.S99898. eCollection 2016.
7
Sarilumab plus methotrexate improves patient-reported outcomes in patients with active rheumatoid arthritis and inadequate responses to methotrexate: results of a phase III trial.托珠单抗联合甲氨蝶呤可改善甲氨蝶呤疗效不佳的活动性类风湿关节炎患者的患者报告结局:一项III期试验结果
Arthritis Res Ther. 2016 Sep 6;18(1):198. doi: 10.1186/s13075-016-1096-9.
8
Affective disturbance in rheumatoid arthritis: psychological and disease-related pathways.类风湿关节炎中的情感障碍:心理及疾病相关途径
Nat Rev Rheumatol. 2016 Sep;12(9):532-42. doi: 10.1038/nrrheum.2016.112. Epub 2016 Jul 14.
9
Biologic interventions for fatigue in rheumatoid arthritis.类风湿关节炎疲劳的生物干预措施。
Cochrane Database Syst Rev. 2016 Jun 6;2016(6):CD008334. doi: 10.1002/14651858.CD008334.pub2.
10
Interleukin-6: an emerging regulator of pathological pain.白细胞介素-6:病理性疼痛的一种新兴调节因子。
J Neuroinflammation. 2016 Jun 7;13(1):141. doi: 10.1186/s12974-016-0607-6.